Mehmet Levent Yuksel
Overview
Explore the profile of Mehmet Levent Yuksel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uslu Yurteri E, Sezer S, Torgutalp M, Yayla M, Sahin Eroglu D, Okatan I, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2023 Jun;
40(2):e2023015.
PMID: 37382076
Background: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare autoimmune disease usually involving small vessels and progressing with necrotizing inflammation. Treatment requires long-term use of immunosuppressive agents to inhibit...
2.
Yayla M, Uslu Yurteri E, Torgutalp M, Sahin Eroglu D, Sezer S, Kelesoglu Dincer A, et al.
Turk J Med Sci
. 2023 Mar;
52(6):1881-1888.
PMID: 36945989
Background: Systemic sclerosis (SSc) is a chronic systemic disease characterized by vascular damage, autoimmunity, and fibrosis in the skin and internal organs. In this study, we tried to determine the...
3.
Aydemir Guloksuz E, Sezer S, Yayla M, Sahin Eroglu D, Uslu Yurteri E, Kelesoglu Dincer A, et al.
J Clin Rheumatol
. 2023 Mar;
29(4):177-182.
PMID: 36881834
Objective: The aims of this study were to compare the frequency of Helicobacter pylori between patients with rheumatoid arthritis (RA) with and without methotrexate (MTX)-related gastrointestinal system (GIS) intolerance, and...
4.
Yayla M, Sahin Eroglu D, Uslu Yurteri E, Kelesoglu Dincer A, Sezer S, Aydemir Guloksuz E, et al.
Clin Rheumatol
. 2022 Jan;
41(5):1457-1463.
PMID: 34988683
Objective: In this study, it was aimed to reveal the hospitalization reasons for patients diagnosed with primary Sjögren syndrome (pSS) and potentially associated factors in a tertiary health center. Method:...
5.
Yayla M, Balci G, Torgutalp M, Sahin Eroglu D, Kelesoglu Dincer A, Aydemir Guloksuz E, et al.
Curr Rheumatol Rev
. 2021 Sep;
18(2):150-156.
PMID: 34517806
Background: Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by microangiopathy, inflammation, fibrosis. Interstitial lung disease (ILD) is common among SSc patients. Objective: This study aims to define the...
6.
Guler D, Kelesoglu Dincer A, Karahan Z, Guler H, Yayla M, Sezer S, et al.
Turk J Med Sci
. 2021 Aug;
51(5):2690-2697.
PMID: 34333900
Background: High mobility group box- 1 (HMGB- 1) is a nuclear protein acting as a proinflammatory molecule. The serum HMGB- 1 levels were found elevated in chronic inflammatory diseases. In...
7.
Yayla M, Karaman Z, Torgutalp M, Kelesoglu Dincer A, Aydemir Guloksuz E, Sezer S, et al.
Clin Rheumatol
. 2020 Mar;
39(9):2689-2696.
PMID: 32221700
Introduction/objectives: Primary Sjögren syndrome (pSS) is usually encountered between the fourth and sixth decades. It is known that the age of onset in autoimmune diseases may affect the clinical features....